{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:00:00Z","timestamp":1790992800181,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbr.2013.09.003","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T19:34:04Z","timestamp":1378582444000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen"],"prefix":"10.1016","volume":"257","author":[{"given":"Lucas M.","family":"Kangussu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana F.","family":"Almeida-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Ant\u00f4nio P.","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Campagnole-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.09.003_bib0005","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/en.2003-0150","article-title":"Minireview: overview of the renin-angiotensin system\u2014an endocrine and paracrine system","volume":"144","author":"Lavoie","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2013.09.003_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(98)00122-0","article-title":"Angiotensin II in central nervous system physiology","volume":"78","author":"Phillips","year":"1998","journal-title":"Regul Pept"},{"key":"10.1016\/j.bbr.2013.09.003_bib0015","first-page":"147825","article-title":"New cardiovascular and pulmonary therapeutic strategies based on the angiotensin-converting enzyme 2\/angiotensin-(1-7)\/mas receptor axis","volume":"2012","author":"Ferreira","year":"2012","journal-title":"Int J Hypertens"},{"issue":"1 Pt 2","key":"10.1016\/j.bbr.2013.09.003_bib0020","first-page":"R89","article-title":"Differential baroreceptor reflex modulation by centrally infused angiotensin peptides","volume":"263","author":"Campagnole-Santos","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","article-title":"The CNS renin-angiotensin system","volume":"326","author":"von Bohlen und Halbach","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0035","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","article-title":"Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain","volume":"293","author":"Becker","year":"2007","journal-title":"Am J Physiol (Heart Circ Physiol)"},{"key":"10.1016\/j.bbr.2013.09.003_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000336340","article-title":"Angiotensin-(1-7) induces peripheral antinociception through mas receptor activation in an opioid-independent pathway","volume":"89","author":"Costa","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.bbr.2013.09.003_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nlm.2011.10.003","article-title":"Angiotensin-(1-7)\/Mas axis integrity is required for the expression of object recognition memory","volume":"97","author":"Lazaroni","year":"2012","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.bbr.2013.09.003_bib0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2005.03.048","article-title":"Brain angiotensin and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680","volume":"1046","author":"Voigt","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2012.06.031","article-title":"Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway","volume":"522","author":"Xing","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2013.09.003_bib0060","first-page":"32","article-title":"Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain","volume":"16","author":"Georgiev","year":"1990","journal-title":"Acta Physiol Pharmacol Bulg"},{"key":"10.1016\/j.bbr.2013.09.003_bib0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0143-4179(97)90021-4","article-title":"Behavioral effects of angiotensin II microinjected into CA1 hippocampal area","volume":"31","author":"Belcheva","year":"1997","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2013.09.003_bib0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00001756-199210000-00026","article-title":"Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze","volume":"3","author":"Kaiser","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2013.09.003_bib0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0006-3223(89)90240-0","article-title":"Positive effects of captopril in the behavioral despair swim test","volume":"25","author":"Giardina","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01283-9","article-title":"The role of angiotensin II in cognition and behaviour","volume":"438","author":"Gard","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0085","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2013.09.003_bib0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(99)00115-1","article-title":"Sex specific behavioural alterations in Mas-deficient mice","volume":"107","author":"Walther","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2012.07.024","article-title":"Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala","volume":"145","author":"Bild","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2013.09.003_bib0100","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1073\/pnas.96.7.3975","article-title":"Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen","volume":"96","author":"Schinke","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2013.09.003_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2012.02.021","article-title":"Cardiovascular responses evoked by activation or blockade of GABA(A) receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen","volume":"1448","author":"Gomes da Silva","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0110","first-page":"239","article-title":"Minor tranquilizers and brain defense systems","volume":"14","author":"Graeff","year":"1981","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1515\/REVNEURO.1993.4.2.181","article-title":"Role of 5-HT in defensive behavior and anxiety","volume":"4","author":"Graeff","year":"1993","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.bbr.2013.09.003_bib0120","first-page":"811","article-title":"Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals","volume":"27","author":"Graeff","year":"1994","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","article-title":"Serotonin, the periaqueductal gray and panic","volume":"28","author":"Graeff","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2013.09.003_bib0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02244182","article-title":"Effects of ritanserin on aversive classical conditioning in humans","volume":"104","author":"Hensman","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.09.003_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02247358","article-title":"5HT drugs in animal models of anxiety","volume":"112","author":"Handley","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.09.003_bib0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(95)98597-J","article-title":"5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research","volume":"65","author":"Griebel","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2013.09.003_bib0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0327(00)00344-X","article-title":"Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety","volume":"61","author":"McNaughton","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2013.09.003_bib0150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0149-7634(01)00047-1","article-title":"Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze","volume":"25","author":"Zangrossi","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2013.09.003_bib0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.09.003_bib0160","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.bbr.2013.09.003_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of \u2018fear\u2019-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-009-1532-5","article-title":"Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats","volume":"205","author":"Aguiar","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.09.003_bib0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbr.2013.09.003_bib0180","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.09.003_bib0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0091-3057(90)90118-2","article-title":"Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset","volume":"36","author":"Costall","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.09.003_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bbr.2013.09.003_bib0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(99)01098-7","article-title":"Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor","volume":"821","author":"Okuyama","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0200","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1074\/jbc.273.19.11867","article-title":"Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene","volume":"273","author":"Walther","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbr.2013.09.003_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0924-977X(98)00031-5","article-title":"Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze","volume":"9","author":"Voigt","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0210","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bbr.2013.09.003_bib0215","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0006-3223(86)90334-3","article-title":"Captopril treatment of depression","volume":"21","author":"Deicken","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0006-3223(88)90010-8","article-title":"Treatment of recurrent unipolar major depression with captopril","volume":"23","author":"Germain","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0225","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.pnpbp.2007.04.002","article-title":"Renin-angiotensin-system gene polymorphisms and depression","volume":"31","author":"Saab","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0230","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0196-9781(93)90063-M","article-title":"Angiotensin(1-7) in the spontaneously hypertensive rat","volume":"14","author":"Kohara","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2013.09.003_bib0235","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0006-3223(90)90034-Y","article-title":"Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats","volume":"27","author":"Martin","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0240","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0006-3223(98)00101-2","article-title":"Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression","volume":"45","author":"Gard","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(94)00481-1","article-title":"Reduction of responses to angiotensin II by antidepressant drugs","volume":"264","author":"Gard","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2013.09.003_bib0250","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.152460","article-title":"Angiotensin regulates release and synthesis of serotonin in brain","volume":"202","author":"Nahmod","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.bbr.2013.09.003_bib0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4088\/JCP.v66n0113","article-title":"Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline","volume":"66","author":"Ball","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0260","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.160.8.1432","article-title":"Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia","volume":"160","author":"Bruce","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0265","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbr.2006.10.002","article-title":"Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze","volume":"176","author":"Drapier","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2013.09.003_bib0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajmg.c.30172","article-title":"Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics","volume":"148","author":"Mathew","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2013.09.003_bib0275","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0924-9338(02)00653-3","article-title":"Beyond the monoamine hypothesis: mechanisms, molecules and methods","volume":"17","author":"Hindmarch","year":"2002","journal-title":"Eur Psychiatry"},{"issue":"Suppl. 14","key":"10.1016\/j.bbr.2013.09.003_bib0280","first-page":"11","article-title":"Monoamine dysfunction and the pathophysiology and treatment of depression","volume":"59","author":"Charney","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2013.09.003_bib0285","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2174\/092986712800099749","article-title":"Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions","volume":"19","author":"Mandrioli","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2013.09.003_bib0290","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"Reneric","year":"1998","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813005536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813005536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T08:58:38Z","timestamp":1539421118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813005536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":58,"alternative-id":["S0166432813005536"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.09.003","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}